Sponsor-Investigators

Suthee Rapisuwon

HCRN-MEL17-309

Phase II single-arm multi-center study of adjuvant ipilimumab in combination with nivolumab in subjects with high-risk ocular melanoma

Status

Open to Accrual

Cancer Types

Melanoma

Locations

California, Columbia University Irving Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Illinois, MD Anderson Cancer Center, Missouri, New York, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Texas, UC San Francisco, Washington, D.C.